Metastatic Renal Cell Carcinoma

NewsGuard 100/100 Score

Renal cell carcinoma (RCC) is the most common form of kidney cancer, accounting for 90% of all kidney cancers. RCC usually begins as a tumor growing in one kidney, but it can also arise in both kidneys.

If a tumor in the kidney is left untreated, it is more likely to spread to other parts of the body. This cancer spread is referred to as metastasis and at this stage, the cancer is referred to as metastatic RCC.

Metastatic RCC is also referred to as stage IV RCC, the most advanced stage of cancer. A cancer is described as Stage IV when it has invaded the lymph system or other organs such as the lungs, brain, bones or liver. Since the adrenal gland is connected to the kidney, the cancer cells often travel there first.

In RCC, the risk of metastasis is significant as most cases are not identified during the early stages of the disease, when the tumor is still small and confined to the kidney. Clinical symptoms are generally mild and nonspecific until the cancer progresses to a more advanced stage. Around 20% to 25% of diagnosed individuals have already reached the metastatic phase of the disease.

How cancer spreads

There are three ways in which cancer spreads, namely through tissue, through the lymph system and through the blood.

  • Tissue: The cancer invades nearby areas of tissue that surround the area where it originally grew
  • Lymph system: The cancer gets into the lymph system, travels along lymph vessels and forms a metastatic tumor in another part of the body
  • Blood: The cancer gets into the blood vessels and travels to another part of the body where it forms a metastatic tumor.

The metastatic tumor that forms is comprised of the same type of cancer cells as the original or “primary” tumor. If RCC spreads to the bone, for example, the cancer cells in the tumor that forms there are cancerous renal cells and the cancer is still called metastatic renal cell cancer rather than bone cancer.


After RCC has spread to other organ systems in the body, a patient’s 5-year survival estimate plummets to 5-15%. A majority of long-term survivors with stage IV RCC (i.e. those that survive more than five years) are patients with solitary metastases that were surgically resected.

Generally, metastatic renal cell carcinoma cannot be cured, albeit the chances of survival may improve if any detectable cancer is removed from the kidney and other affected organs


Surgery is often not an option and treatment is focused on slowing disease progression and alleviating symptoms. Surgical removal of the cancer may be possible in cases where the tumor and metastasis can be isolated. Surgery may be performed to remove as much of the tumor as possible (partial nephrectomy) or the whole kidney may be removed (partial nephrectomy). Alternatively, a radical nephrectomy may be performed, where the entire kidney, attached adrenal gland, nearby lymph nodes and other surrounding tissue is removed.

A person with stage IV RCC will be assessed by their doctor to determine their eligibility for surgery. If surgery is not an option, alternative approaches may be used and these are described below:

Biological therapy (immunotherapy)

This involves the use of drugs that manipulate the immune system to target cancer cells. Examples of these drugs include interferon and aldesleukin.

Targeted therapy

These treatments specifically block the abnormal signals in kidney tumor cells, which allow the cells to proliferate. The drugs axitinib, sunitinib and bevacizumab, for example, block the signals that enable the growth of blood vessels that supply the tumor cells with nutrients, enabling their spread. The drugs everolimus and temsirolimus block the signals that enable the growth and survival of tumor cells.


Here, a substance is used to occlude blood vessels so that blood flow to cancer cells is blocked. The main disadvantage of this approach is that the substance used may also block blood flow to healthy cells.


High-energy radiation is used to target cancer cells, although this tends to be unsuccessful when the cancer has spread to many parts of the body. On the other hand, palliative radiotherapy has an important role in supportive care for metastatic disease.

Further Reading

Last Updated: Feb 27, 2019

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2019, February 27). Metastatic Renal Cell Carcinoma. News-Medical. Retrieved on May 23, 2024 from

  • MLA

    Robertson, Sally. "Metastatic Renal Cell Carcinoma". News-Medical. 23 May 2024. <>.

  • Chicago

    Robertson, Sally. "Metastatic Renal Cell Carcinoma". News-Medical. (accessed May 23, 2024).

  • Harvard

    Robertson, Sally. 2019. Metastatic Renal Cell Carcinoma. News-Medical, viewed 23 May 2024,


  1. Graeme Hills Graeme Hills United Kingdom says:

    I have metastatic RCC - spread to lymph nodes and left lung.  Just stopped SUNITINIB as it stopped working. Also had a blockage removed from the left lung and just completed radiotherapy course for the lung 'issue'.  Coughing quite a lot and getting very short of breath with very little exertion.. are the symptoms normal after radiotherapy to a lung?  Thanks..

    • Myron Henderson Myron Henderson United States says:

      I'm sorry to hear that you have complications, I would advise asking your health provider. I too was diagnosed with RCC stage 4 last December. I was somewhat lucky in the fact that I only had metastasis to my sternum and a ribcage. They did have to take my left kidney but all in all radiation seems to be working in controlling my active areas and lucky that I haven't had worst. Best of luck to you and stay strong.

    • Mike Scanlon Mike Scanlon United States says:

      I hope that now a year later finds you well.  You story sounds a bit like mine, I had RCC spread to both my lungs.  Dr's used IL2 and they dissolved away. . though the treatment was pretty devastating. . fast forward 9 years and a new spread to my adrenal.. the point here is that (from what I understand) treatment is moving away from IL2 to just approved Nivolumab. . its a once every other week, IV infusion (takes an hour). . easy to take, higher rate of success and has some durability. . Best of luck.. keep up the fight.

      • Fahri Bayiroglu Fahri Bayiroglu Turkey says:

        My father, 77 years old, had a surgery which removed his right kidney with tumor 7 years ago. Now he has RCC spread to both his lungs. Doctors advised him to get a second surgery and get them removed by open lung operation. When the doctors treated your spreads, how big the nodules in your lungs? Why did not they think to remove your nodules by surgery? Thanks for your reply in advance. I wish you and all the patients a clear recovery and goood healths.

  2. Dennis Harris Dennis Harris United States says:

    Just told of nodules in both lungs and that rcc for which they removed my right lung is suspected to have matastisized to that sight. CT scan next week and then have to wait another week for results. What can i expect and how do you cope with waiting to find out.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.